https://www.selleckchem.com/pr....oducts/cobimetinib-g
Serum Fstl1 at 4h post-surgery had a high predictive ability for AKI, severe AKI and major renal adverse events(MAKE) (AUC=0.713, 0.869 and 0.808, respectively). Adding postoperative 4h serum Fstl1 to the clinical model can significantly improve the predictive performance of the model. Higher serum Fstl1 levels at 4h post-surgery is associated with higher odds of AKI after cardiac surgery, and when added to clinical model and Cleveland Score, serum Fstl1 levels at 4h after cardiac surgery enhanced early prediction of
Like
Comment
Share
